| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9385736 | Respiratory Medicine | 2005 | 13 Pages |
Abstract
In the future, it will be important to establish the precise value of the different treatments available for COPD-evaluating both clinical and physiological endpoints and using the data to more accurately define candidate patients accordingly. The challenge will be to develop this base of knowledge in order to shape future research and allow clinicians to deliver tailored COPD management programmes for the growing number of patients afflicted with this disease.
Keywords
FEV1NPPVSGRQNETTLVRSPDE4LTOTLTB4HRQOLIL-8ATSICSNF-κBQOLERSSFCNACQuality of lifeN-acetylcysteineNational Emphysema Treatment TrialLong-acting β2-agonistEuropean Respiratory SocietyAmerican Thoracic SocietyInterleukin-8BronchodilatorsChronic obstructive pulmonary diseaseCOPDNon-invasive ventilationtumour necrosis factor-alphaForced expiratory volume in 1 sLong-term oxygen therapyLABAGlobal Initiative for Chronic Obstructive Lung DiseaseGoldTNF-αNuclear factor-kappa Bphosphodiesterase-4Leukotriene B4Ventilation/perfusion ratioSt. George's Respiratory QuestionnaireInhaled corticosteroidsInhaled corticosteroidHealth-related quality of life
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Nicola A. Hanania, Nicolino Ambrosino, Peter Calverley, Mario Cazzola, Claudio F Donner, Barry Make,